19 datasets found
  1. c

    Latin America's Biologics Drug Development market will be USD 377.56 million...

    • cognitivemarketresearch.com
    pdf,excel,csv,ppt
    Updated Feb 15, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Cognitive Market Research (2024). Latin America's Biologics Drug Development market will be USD 377.56 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031. [Dataset]. https://www.cognitivemarketresearch.com/regional-analysis/south-america-biologics-drug-development-market-report
    Explore at:
    pdf,excel,csv,pptAvailable download formats
    Dataset updated
    Feb 15, 2024
    Dataset authored and provided by
    Cognitive Market Research
    License

    https://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy

    Time period covered
    2021 - 2033
    Area covered
    Latin America, Region
    Description

    Latin America's Biologics Drug Development market will be USD 377.56 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031. The market is foreseen to reach USD 708.4 million by 2031 due to increasing prevalence of chronic diseases.

  2. w

    Global Healthcare CMO Market Research Report: By Service Type (Contract...

    • wiseguyreports.com
    Updated Dec 4, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2024). Global Healthcare CMO Market Research Report: By Service Type (Contract Manufacturing, Process Development, Quality Assurance), By Therapeutic Area (Oncology, Cardiovascular, Central Nervous System), By Client Type (Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies), By Product Type (Small Molecules, Large Molecules, Cell and Gene Therapies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/reports/healthcare-cmo-market
    Explore at:
    Dataset updated
    Dec 4, 2024
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 20236.88(USD Billion)
    MARKET SIZE 20247.42(USD Billion)
    MARKET SIZE 203213.5(USD Billion)
    SEGMENTS COVEREDService Type, Therapeutic Area, Client Type, Product Type, Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSRising demand for biologics, Increasing R&D investment, Growing regulatory complexity, Expansion of outsourcing services, Technological advancements in manufacturing
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDWuXi AppTec, Merck KGaA, Lonza, Novartis, Catalent, Recipharm, PPD, Baxter, Snyder Pharmaceuticals, Aenova, Evonik Industries, Resilience, Boehringer Ingelheim, Samsung Biologics, Famar
    MARKET FORECAST PERIOD2025 - 2032
    KEY MARKET OPPORTUNITIESIncreasing demand for personalized medicine, Growth of biologics and biosimilars, Expansion of outsourcing trends, Advancements in biomanufacturing technologies, Rise in healthcare expenditure globally
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.78% (2025 - 2032)
  3. h

    Biopharmaceutical Logistics Services Market - Global Growth Opportunities...

    • htfmarketinsights.com
    pdf & excel
    Updated Nov 18, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    HTF Market Intelligence (2024). Biopharmaceutical Logistics Services Market - Global Growth Opportunities 2024-2030 [Dataset]. https://www.htfmarketinsights.com/report/1176740-biopharmaceutical-logistics-services-market
    Explore at:
    pdf & excelAvailable download formats
    Dataset updated
    Nov 18, 2024
    Dataset authored and provided by
    HTF Market Intelligence
    License

    https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy

    Time period covered
    2019 - 2031
    Area covered
    Global
    Description

    Global Biopharmaceutical Logistics Services is segmented by Application (Pharmaceuticals, Healthcare, Drug manufacturers), Type (Cold chain logistics, Drug distribution, Inventory management) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)

  4. Biologics Market

    • transparencymarketresearch.com
    csv, pdf
    Updated Jul 4, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Transparency Market Research (2025). Biologics Market [Dataset]. https://www.transparencymarketresearch.com/global-biologics-market.html
    Explore at:
    csv, pdfAvailable download formats
    Dataset updated
    Jul 4, 2025
    Dataset authored and provided by
    Transparency Market Research
    License

    https://www.transparencymarketresearch.com/privacy-policy.htmlhttps://www.transparencymarketresearch.com/privacy-policy.html

    Time period covered
    2023 - 2031
    Area covered
    Worldwide
    Description
    • The global industry was valued at US$ 515.6 Bn in 2022
    • It is projected to grow at a CAGR of 6.9% from 2023 to 2031 and reach more than US$ 855.8 Bn by 2031

    Market Introduction

    AttributeDetail
    DriverStrong Pipeline with Accelerated Approval

    Regional Outlook of Global Biologics Industry

    AttributeDetail
    Leading RegionNorth America

    Global Biologics Market Snapshot

    AttributeDetail
    Market Value in 2022US$ 515.6 Bn
    Market Forecast Value in 2031More than US$ 855.8 Bn
    Growth Rate (CAGR)6.9%
    Forecast Period2023-2031
    Historical Data Available for2017-2021
    Quantitative UnitsUS$ Bn for Value
    Market AnalysisIt includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.
    Competition LandscapeCompany profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
    FormatElectronic (PDF) + Excel
    Market Segmentation
    • Product
      • Monoclonal Antibodies
      • Recombinant Proteins
      • Vaccines
      • Cell & Gene Therapy
      • Others
    • Application
      • Oncology
      • Autoimmune & Immunological Disorders
      • Hematological Disorders
      • Infectious Diseases
      • Others (Cardiovascular Disorders, etc.)
    • Manufacturing
      • Outsourced
      • In-house
    Regions Covered
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
    Countries Covered
    • U.S.
    • Canada
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Brazil
    • Mexico
    • GCC Countries
    • South Africa
    Companies Profiled
    • AbbVie
    • Amgen
    • AstraZeneca
    • Bristol-Myers Squibb Company
    • Eli Lilly
    • Gilead Sciences, Inc.
    • GlaxoSmithKline
    • Johnson & Johnson Services Inc.
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • F. Hoffmann-La Roche AG and Others
    • Other Players
    Customization ScopeAvailable upon request
    PricingAvailable upon request
  5. w

    Global In Silico Drug Discovery Market Research Report: By Drug Type (Small...

    • wiseguyreports.com
    Updated Aug 10, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2024). Global In Silico Drug Discovery Market Research Report: By Drug Type (Small Molecules, Biologics, Peptides, Nucleic Acids), By Application (Oncology, Central Nervous System Disorders, Cardiovascular Diseases, Infectious Diseases), By Technology (Molecular Docking, Molecular Dynamics, Quantitative Structure-Activity Relationship (QSAR), Machine Learning, Artificial Intelligence), By End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutions, Contract Research Organizations (CROs), Government Agencies), By Service Type (Target Identification, Lead Optimization, Virtual Screening, Toxicity Prediction, Clinical Trial Design) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/reports/in-silico-drug-discovery-market
    Explore at:
    Dataset updated
    Aug 10, 2024
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    Jan 8, 2024
    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 20237.47(USD Billion)
    MARKET SIZE 20248.63(USD Billion)
    MARKET SIZE 203227.3(USD Billion)
    SEGMENTS COVEREDDrug Type ,Application ,Technology ,End User ,Service Type ,Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSTechnological advancements increasing drug development costs rising demand for personalized medicine government initiatives and strategic collaborations
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDGenedata ,Cyclica ,Insilico Medicine ,BioSolveIT ,Accelrys ,Atomwise ,XtalPi ,Molecular Simulations ,BenevolentAI ,Insilicobion ,Certara ,Exscientia ,OpenEye Scientific Software
    MARKET FORECAST PERIOD2025 - 2032
    KEY MARKET OPPORTUNITIESGrowing demand for personalized medicine Advancements in artificial intelligence and machine learning Increasing prevalence of chronic diseases Government support for drug discovery Rising adoption of cloudbased drug discovery platforms
    COMPOUND ANNUAL GROWTH RATE (CAGR) 15.49% (2025 - 2032)
  6. h

    Global Biologics Market Roadmap to 2031

    • htfmarketinsights.com
    pdf & excel
    Updated Jan 9, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    HTF Market Intelligence (2025). Global Biologics Market Roadmap to 2031 [Dataset]. https://www.htfmarketinsights.com/report/4140652-biologics-market
    Explore at:
    pdf & excelAvailable download formats
    Dataset updated
    Jan 9, 2025
    Dataset authored and provided by
    HTF Market Intelligence
    License

    https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy

    Time period covered
    2019 - 2031
    Area covered
    Global
    Description

    Global Biologics is segmented by Application (Healthcare, Cancer Treatment, Immunotherapy, Autoimmune Diseases, R&D), Type (Monoclonal Antibodies, Gene Therapy, Vaccines, Recombinant Proteins, Biosimilars) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)

  7. h

    Contract Biomanufacturing Services Market - Global Size & Outlook 2019-2030

    • htfmarketinsights.com
    pdf & excel
    Updated Nov 14, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    HTF Market Intelligence (2024). Contract Biomanufacturing Services Market - Global Size & Outlook 2019-2030 [Dataset]. https://www.htfmarketinsights.com/report/1525836-contract-biomanufacturing-services-market
    Explore at:
    pdf & excelAvailable download formats
    Dataset updated
    Nov 14, 2024
    Dataset authored and provided by
    HTF Market Intelligence
    License

    https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy

    Time period covered
    2019 - 2031
    Area covered
    Global
    Description

    Global Contract Biomanufacturing Services is segmented by Application (Pharmaceuticals, Biotech, Healthcare, Food & Beverage, Cosmetics), Type (Cell Line Development, Protein Production, Vaccine Manufacturing, Gene Therapy, Bio-Pharmaceutical Manufacturing) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)

  8. w

    Global Biopharmaceutical Oral Drug Delivery Market Research Report: By Drug...

    • wiseguyreports.com
    Updated Aug 24, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2024). Global Biopharmaceutical Oral Drug Delivery Market Research Report: By Drug Type (Small Molecules, Large Molecules, Oligonucleotides, Peptides), By Route of Administration (Oral, Transmucosal, Sublingual, Buccal), By Formulation Type (Tablets, Capsules, Liquids, Powders), By Delivery Mechanism (Controlled Release, Sustained Release, Targeted Delivery, Enhanced Absorption), By Therapeutic Application (Cancer, Cardiovascular Diseases, Central Nervous System Disorders, Infectious Diseases) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/cn/reports/biopharmaceutical-oral-drug-delivery-market
    Explore at:
    Dataset updated
    Aug 24, 2024
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    Jan 8, 2024
    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 202328.39(USD Billion)
    MARKET SIZE 202430.65(USD Billion)
    MARKET SIZE 203256.6(USD Billion)
    SEGMENTS COVEREDDrug Type ,Route of Administration ,Formulation Type ,Delivery Mechanism ,Therapeutic Application ,Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSRising prevalence of chronic diseases Technological advancements Growing demand for noninvasive drug delivery Increasing focus on patient convenience Surge in RampD investments
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDScient'x S.A. ,Hemispherx Biopharma, Inc. ,Zogenix, Inc. ,Alnylam Pharmaceuticals, Inc ,AcelRx Pharmaceuticals, Inc. ,PeptonBio ,Enteris BioPharma, Inc ,Orexo AB ,Zealand Pharma A/S ,Cosmo Pharmaceuticals N.V. ,Assertio Holdings, Inc. ,Emisphere Technologies, Inc ,InVivo Therapeutics ,Cadence Pharmaceuticals, Inc.
    MARKET FORECAST PERIOD2025 - 2032
    KEY MARKET OPPORTUNITIESControlled release oral drug delivery Personalized medicine Targeted oral drug delivery Nanomedicine in oral drug delivery and Artificial intelligence in oral drug development
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.96% (2025 - 2032)
  9. w

    Global Licensing Partnering Terms Agreements in Pharma, Biotech Diagnostics...

    • wiseguyreports.com
    Updated Dec 4, 2024
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2024). Global Licensing Partnering Terms Agreements in Pharma, Biotech Diagnostics Market Research Report: By Type of Agreement (Exclusive License, Non-Exclusive License, Co-Promotion Agreement, Collaboration Agreement), By Therapeutic Area (Oncology, Cardiovascular, Neurology, Infectious Diseases, Autoimmune Disorders), By Partnership Structure (Academic Partnerships, Corporate Partnerships, Joint Ventures, Franchise Agreements), By Geographical Focus (North America, Europe, Asia-Pacific, Latin America) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/reports/licensing-partnering-terms-agreements-in-pharma-biotech-diagnostics-market
    Explore at:
    Dataset updated
    Dec 4, 2024
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 202329.26(USD Billion)
    MARKET SIZE 202430.75(USD Billion)
    MARKET SIZE 203245.7(USD Billion)
    SEGMENTS COVEREDType of Agreement, Therapeutic Area, Partnership Structure, Geographical Focus, Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSRegulatory compliance challenges, Intellectual property concerns, Competitive landscape evolution, Emerging market opportunities, Collaborative innovation strategies
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDRoche, Gilead Sciences, Pfizer, Novartis, BristolMyers Squibb, Regeneron Pharmaceuticals, Takeda Pharmaceutical, Biogen, AbbVie, Johnson and Johnson, Merck and Co, GlaxoSmithKline, Amgen, Sanofi, AstraZeneca
    MARKET FORECAST PERIOD2025 - 2032
    KEY MARKET OPPORTUNITIESExpanding digital health collaborations, Increasing biologics licensing agreements, Growth in personalized medicine partnerships, Rising demand for orphan drug development, Strategic alliances for emerging therapies
    COMPOUND ANNUAL GROWTH RATE (CAGR) 5.08% (2025 - 2032)
  10. w

    Global Pharmaceutical Cmo And Cdmo Market Research Report: By Service Type...

    • wiseguyreports.com
    Updated Mar 6, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2025). Global Pharmaceutical Cmo And Cdmo Market Research Report: By Service Type (Contract Manufacturing, Contract Development and Manufacturing, Biopharmaceutical Services), By Therapeutic Area (Oncology, Cardiovascular, Central Nervous System, Metabolic Disorders, Infectious Diseases), By Product Type (Small Molecules, Biologics, Biosimilars, Cell and Gene Therapies), By Service Model (Integrated, Standalone, Platform-Based), By Project Phase (Discovery and Development, Clinical Trials, Commercial Manufacturing) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/es/reports/pharmaceutical-cmo-and-cdmo-market
    Explore at:
    Dataset updated
    Mar 6, 2025
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    Sep 24, 2025
    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 2023117.92(USD Billion)
    MARKET SIZE 2024128.36(USD Billion)
    MARKET SIZE 2032252.81(USD Billion)
    SEGMENTS COVEREDService Type ,Therapeutic Area ,Product Type ,Service Model ,Project Phase ,Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSRising demand for personalized medicine Increased adoption of outsourcing to reduce costs Technological advancements in drug discovery and development Growing prevalence of chronic diseases Expansion of biopharmaceutical industry
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDCatalent ,Alcami ,Recipharm AB ,Merck KGaA ,Lonza ,Boehringer Ingelheim ,CordenPharma International ,Samsung Biologics ,Thermo Fisher Scientific ,Medpace Holdings, Inc. ,Syneos Health ,WuXi AppTec ,Charles River Laboratories International ,Patheon N.V. ,Capsugel
    MARKET FORECAST PERIOD2025 - 2032
    KEY MARKET OPPORTUNITIESIncreased drug development outsourcing Growing demand for biologics Expansion into emerging markets Focus on personalized medicine Technological advancements in drug manufacturing
    COMPOUND ANNUAL GROWTH RATE (CAGR) 8.85% (2025 - 2032)
  11. w

    Global Contract Development And Manufacturing Organization Cdmo Outsourcing...

    • wiseguyreports.com
    Updated Aug 24, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2024). Global Contract Development And Manufacturing Organization Cdmo Outsourcing Market Research Report: By Therapeutic Area (Oncology, Infectious Diseases, Central Nervous System (CNS), Cardiovascular Diseases, Respiratory Diseases), By Molecule Type (Small Molecules, Large Molecules, Oligonucleotides, Cell and Gene Therapies), By Service Type (Early Development, Clinical Development, Manufacturing, Regulatory Affairs, Packaging and Distribution), By Scale of Operation (Small-Scale, Mid-Scale, Large-Scale), By End-User (Pharmaceutical and Biotechnology Companies, Medical Device Companies, Academic and Research Institutions, Government Agencies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/es/reports/contract-development-and-manufacturing-organization-cdmo-outsourcing-market
    Explore at:
    Dataset updated
    Aug 24, 2024
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    Jan 8, 2024
    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 2023151.45(USD Billion)
    MARKET SIZE 2024163.17(USD Billion)
    MARKET SIZE 2032296.4(USD Billion)
    SEGMENTS COVEREDTherapeutic Area ,Molecule Type ,Service Type ,Scale of Operation ,End-User ,Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSGrowing Demand for Outsourcing Technological Advancements Increased Focus on Efficiency Regulatory Complexities Rise of Biologics and Specialty Drugs
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDPatheon ,Merck Group ,Thermo Fisher Scientific ,Charles River Laboratories ,Samsung BioLogics ,Agenus ,Akesobio ,Catalent ,Boehringer Ingelheim ,WuXi Advanced Therapies ,Lonza ,FUJIFILM Diosynth Biotechnologies ,Sartorius ,ThermoGenesis Holdings ,BioRad Laboratories
    MARKET FORECAST PERIOD2025 - 2032
    KEY MARKET OPPORTUNITIESBiotechnological advancements outsourcing advantages personalized medicine expansion technological advancements growing demand for biologics
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.74% (2025 - 2032)
  12. w

    Global General Drug Distribution Market Research Report: By Distribution...

    • wiseguyreports.com
    Updated Sep 24, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2024). Global General Drug Distribution Market Research Report: By Distribution Channel (Wholesalers/Distributors, Retail Pharmacies, Hospitals and Clinics, Online Pharmacies, Specialty Pharmacies), By Drug Type (Generic Drugs, Branded Drugs, Biologics, Over-the-Counter (OTC) Drugs, Prescription Drugs), By Dosage Form (Oral Solid, Orals Liquid/Suspension, Injectables, Topicals, Inhalation, Others (transdermal, ophthalmic)), By Therapeutic Area (Central Nervous System (CNS), Cardiovascular, Oncology, Infectious Diseases, Musculoskeletal, Respiratory, Gastrointestinal, Others (endocrinology, dermatology, ophthalmology)) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/cn/reports/general-drug-distribution-market
    Explore at:
    Dataset updated
    Sep 24, 2024
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    Jan 9, 2024
    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 2023748.27(USD Billion)
    MARKET SIZE 2024824.22(USD Billion)
    MARKET SIZE 20321786.7(USD Billion)
    SEGMENTS COVEREDDistribution Channel ,Drug Type ,Dosage Form ,Therapeutic Area ,Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSIncreasing demand for generic drugs Technological advancements Growing prevalence of chronic diseases Stringent regulatory policies
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDAlliance Healthcare ,HD Supply ,Morrisons ,McKesson ,Sanofi ,Cardinal Health ,Owens & Minor ,Roche ,Amerisource ,Novartis ,GlaxoSmithKline ,Medline Industries ,Pfizer
    MARKET FORECAST PERIOD2025 - 2032
    KEY MARKET OPPORTUNITIESAging population technological advancements expanding biopharmaceutical sector
    COMPOUND ANNUAL GROWTH RATE (CAGR) 10.15% (2025 - 2032)
  13. w

    Global Liposomal Lipid Drug Delivery Systems Market Research Report: By Drug...

    • wiseguyreports.com
    Updated Sep 24, 2024
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    wWiseguy Research Consultants Pvt Ltd (2024). Global Liposomal Lipid Drug Delivery Systems Market Research Report: By Drug Type (Small Molecule Therapeutics, Biologics), By Application (Oncology, Infectious Diseases, Central Nervous System Disorders, Rare Diseases, Cardiovascular Diseases), By Composition (Cationic Liposomes, Anionic Liposomes, Neutral Liposomes, pH-Sensitive Liposomes), By Size (Small Unilamellar Vesicles (SUVs), Large Unilamellar Vesicles (LUVs), Multilamellar Vesicles (MLVs)) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032. [Dataset]. https://www.wiseguyreports.com/de/reports/liposomal-lipid-drug-delivery-systems-market
    Explore at:
    Dataset updated
    Sep 24, 2024
    Dataset authored and provided by
    wWiseguy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    Jan 9, 2024
    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2024
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 20239.42(USD Billion)
    MARKET SIZE 202410.38(USD Billion)
    MARKET SIZE 203222.5(USD Billion)
    SEGMENTS COVEREDDrug Type ,Application ,Composition ,Size ,Regional
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    KEY MARKET DYNAMICSGrowing demand for targeted drug delivery Advances in liposome technology Increasing prevalence of chronic diseases Rising focus on personalized medicine Technological advancements in drug delivery systems
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDLipoCure, Inc. ,Marathon Pharmaceuticals LLC ,BioDelivery Sciences International, Inc. ,Pacira Pharmaceuticals, Inc. ,Vanda Pharmaceuticals Inc. ,Teva Pharmaceutical Industries Ltd. ,Sarepta Therapeutics, Inc. ,Intas Pharmaceuticals Ltd. ,Roche Holding AG ,ProCred Pharma LLC ,Greystone Therapeutics, Inc. ,Spectrum Pharmaceuticals, Inc. ,Atossa Therapeutics, Inc. ,Sun Pharmaceutical Industries Ltd. ,EnGeneIC Ltd.
    MARKET FORECAST PERIOD2025 - 2032
    KEY MARKET OPPORTUNITIESTargeted Drug Delivery Personalized Medicine Biopharmaceutical Advancement Nanomedicine Growth Cancer Treatment Innovations
    COMPOUND ANNUAL GROWTH RATE (CAGR) 10.15% (2025 - 2032)
  14. h

    Global Cell Line Development for Biologics Market Roadmap to 2030

    • htfmarketinsights.com
    pdf & excel
    Updated Nov 18, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    HTF Market Intelligence (2024). Global Cell Line Development for Biologics Market Roadmap to 2030 [Dataset]. https://www.htfmarketinsights.com/report/4283821-cell-line-development-for-biologics-market
    Explore at:
    pdf & excelAvailable download formats
    Dataset updated
    Nov 18, 2024
    Dataset authored and provided by
    HTF Market Intelligence
    License

    https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy

    Time period covered
    2019 - 2031
    Area covered
    Global
    Description

    Global Cell Line Development for Biologics is segmented by Application (Biopharmaceuticals, Vaccine Development, Gene Therapy), Type (Mammalian Cell Lines, Insect Cell Lines, CHO Cells) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)

  15. h

    Global Biotechnology Services Market Scope & Changing Dynamics 2023-2031

    • htfmarketinsights.com
    pdf & excel
    Updated Jan 9, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    HTF Market Intelligence (2025). Global Biotechnology Services Market Scope & Changing Dynamics 2023-2031 [Dataset]. https://www.htfmarketinsights.com/report/4140552-biotechnology-services-market
    Explore at:
    pdf & excelAvailable download formats
    Dataset updated
    Jan 9, 2025
    Dataset authored and provided by
    HTF Market Intelligence
    License

    https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy

    Time period covered
    2019 - 2031
    Area covered
    Global
    Description

    Global Biotechnology Services is segmented by Application (Healthcare, Pharmaceuticals, Research, Biotechnology, Diagnostics), Type (Research, Contract manufacturing, Clinical trials, Genetic, Biopharmaceutical) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)

  16. h

    Plant-based Biologics Market - Global Share, Size & Changing Dynamics...

    • htfmarketinsights.com
    pdf & excel
    Updated Jan 4, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    HTF Market Intelligence (2025). Plant-based Biologics Market - Global Share, Size & Changing Dynamics 2019-2031 [Dataset]. https://www.htfmarketinsights.com/report/3060979-plant-based-biologics-market
    Explore at:
    pdf & excelAvailable download formats
    Dataset updated
    Jan 4, 2025
    Dataset authored and provided by
    HTF Market Intelligence
    License

    https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy

    Time period covered
    2019 - 2031
    Area covered
    Global
    Description

    Global Plant-based Biologics is segmented by Application (Agriculture, Pharmaceuticals, Biotech) , Type (Protein-based, Enzyme-based, Microbial) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)

  17. h

    Plant Genomics Market - Global Outlook 2020-2032

    • htfmarketinsights.com
    pdf & excel
    Updated Jun 28, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    HTF Market Intelligence (2025). Plant Genomics Market - Global Outlook 2020-2032 [Dataset]. https://www.htfmarketinsights.com/report/4361483-plant-genomics-market
    Explore at:
    pdf & excelAvailable download formats
    Dataset updated
    Jun 28, 2025
    Dataset authored and provided by
    HTF Market Intelligence
    License

    https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy

    Time period covered
    2019 - 2031
    Area covered
    Global
    Description

    Global Plant Genomics is segmented by Application (Agriculture, biotech research, food security, climate adaptation, seed production), Type (CRISPR crops, drought-resistant seeds, high-yield varieties, disease-resistant plants, biofortified crops) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)

  18. h

    Global Viral Vector Manufacturing CDMO Services Market Scope & Changing...

    • htfmarketinsights.com
    pdf & excel
    Updated Feb 21, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    HTF Market Intelligence (2025). Global Viral Vector Manufacturing CDMO Services Market Scope & Changing Dynamics 2024-2032 [Dataset]. https://www.htfmarketinsights.com/report/4352128-viral-vector-manufacturing-cdmo-services-market
    Explore at:
    pdf & excelAvailable download formats
    Dataset updated
    Feb 21, 2025
    Dataset authored and provided by
    HTF Market Intelligence
    License

    https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy

    Time period covered
    2019 - 2031
    Area covered
    Global
    Description

    Global Viral Vector Manufacturing CDMO Services is segmented by Application (Gene Therapy, Vaccine Development, Cancer Therapy, Genetic Research, Biopharmaceuticals), Type (AAV, Lentivirus, Adenovirus, Retrovirus, Herpes Simplex Virus) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)

  19. h

    Microcarrier System Market - Global Share, Size & Changing Dynamics...

    • htfmarketinsights.com
    pdf & excel
    Updated Jan 9, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    HTF Market Intelligence (2025). Microcarrier System Market - Global Share, Size & Changing Dynamics 2019-2031 [Dataset]. https://www.htfmarketinsights.com/report/4112992-microcarrier-system-market
    Explore at:
    pdf & excelAvailable download formats
    Dataset updated
    Jan 9, 2025
    Dataset authored and provided by
    HTF Market Intelligence
    License

    https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy

    Time period covered
    2019 - 2031
    Area covered
    Global
    Description

    Global Microcarrier System is segmented by Application (Biotech, medical research, laboratory), Type (Microcarrier, System, Biotech, Medical, Cell culture) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)

  20. Not seeing a result you expected?
    Learn how you can add new datasets to our index.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
Cognitive Market Research (2024). Latin America's Biologics Drug Development market will be USD 377.56 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031. [Dataset]. https://www.cognitivemarketresearch.com/regional-analysis/south-america-biologics-drug-development-market-report

Latin America's Biologics Drug Development market will be USD 377.56 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.

Explore at:
pdf,excel,csv,pptAvailable download formats
Dataset updated
Feb 15, 2024
Dataset authored and provided by
Cognitive Market Research
License

https://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy

Time period covered
2021 - 2033
Area covered
Latin America, Region
Description

Latin America's Biologics Drug Development market will be USD 377.56 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031. The market is foreseen to reach USD 708.4 million by 2031 due to increasing prevalence of chronic diseases.

Search
Clear search
Close search
Google apps
Main menu